# Kadance

> Genomics\-based precision health management embedded in life and critical illness insurance policies

## At a glance

| Field | Value |
| --- | --- |
| Category | Specialty Solutions |
| Type | Solutions Provider |
| Region | NA |
| Headquarters | Huntsville, Alabama |
| Founded | 2021 |
| Stage | Growth |
| Employees | 11-50 |
| Funding | Seed |

## Overview

Kadance is a genomics-based precision health management platform for life, critical illness, and long-term care insurance carriers. The company partners with insurers to deliver genetic testing and clinical support programs as value-add benefits embedded in insurance policies, targeting policyholders at risk for hereditary cancers and adverse drug reactions.

The platform integrates three core services -- hereditary cancer risk assessment, pharmacogenomics testing, and personalized health navigation -- delivered as a living benefit rider or standalone consumer offering. Kadance operates its own genetic testing lab through its 2023 acquisition of Kailos Genetics, which has tested over 50,000 patients and detected more than seven million genetic variants. Clinical support is provided by oncology nurse navigators and molecular pathologists.

The company distributes through insurance carriers including Chubb, Nationwide, and Hannover Re. Kadance, formerly known as healthOme, rebranded in January 2025 and closed a Preferred Seed round in May 2024 led by American Family Ventures and AllegisNL Capital. A strategic investment from Nassau Financial Group followed in 2026.

## Products & services

### Hereditary Cancer Risk Assessment

DNA-based testing to identify inherited cancer predispositions such as BRCA mutations and Lynch syndrome markers. Results inform personalized health management decisions for policyholders.

**Key features:**

- Hereditary cancer gene panel testing
- Actionable risk reports with clinical interpretation
- Access to oncology nurse navigators for follow\-up support

*Target users:* Life and critical illness insurance policyholders

### Pharmacogenomics Testing

Genetic analysis that determines how individuals respond to medications based on their DNA. The service identifies optimal drug selections and dosages to reduce adverse reactions.

**Key features:**

- Multi\-drug compatibility analysis
- Medication efficacy and risk profiling
- Clinical guidance on dosage optimization

*Target users:* Insurance policyholders and healthcare consumers

### Precision Health Management Program

An ongoing personalized health guidance program that integrates genetic insights with clinical consultation. Available as an insurance benefit rider or direct-to-consumer product.

**Key features:**

- Integrated genomics testing and clinical navigation
- Access to oncology nurse navigators and molecular pathologists
- Available as insurance rider or consumer\-direct subscription

*Target users:* Life, critical illness, and long\-term care insurance carriers and their policyholders

## Category & focus

- Subcategories: Genomics\-based health management, living benefit riders, pharmacogenomics
- Insurance verticals: Life & Annuity, Group Benefits, Reinsurance
- Target customers: Carriers, Reinsurers, Consumers

## Notable customers

- Chubb
- Nationwide
- Hannover Re
- Nassau Financial Group

## Links

- Website: <https://kadance.com>
- Directory profile: <https://insurtechlist.com/companies/kadance/>
- News: <https://www.kadance.com/newsroom>
- Team: <https://www.kadance.com/meet-the-team>
- Careers: <https://www.kadance.com/careers>
- Insurance professionals: <https://www.kadance.com/insurance-professionals>

---

*Last updated: 2026\-06\-15*